Table 3.

pMTCT outcome measures

Study measure	Numerator/Denominator
1. Uptake of HIV counseling and testing	$\frac{\#\mathrm{women}\mathrm{counseled}\mathrm{and}\mathrm{tested}\mathrm{for}\mathrm{HIV}\mathrm{in}\mathrm{their}\mathrm{first}\mathrm{ANC}\mathrm{visit}}{\#\mathrm{first}\mathrm{ANC}\mathrm{visits}}$
2. Use of appropriate ARVs in pregnancy for prophylaxis or initiation of cART	$\frac{\#\mathrm{HIV}‒\mathrm{infected}\mathrm{pregnant}\mathrm{women}\mathrm{starting}\mathrm{AZT}\mathrm{prophylaxis}\mathrm{or}\mathrm{cART}}{\#\mathrm{women}\mathrm{testing}\mathrm{HIV}‒\mathrm{positive}\mathrm{in}\mathrm{ANC}3\mathrm{months}\mathrm{previously}}$
3. Infant HIV determination	$\frac{\#\mathrm{infants}<6\mathrm{weeks}\mathrm{of}\mathrm{age}\mathrm{receiving}\mathrm{a}\mathrm{PCR}\mathrm{test}}{\#\mathrm{women}\mathrm{testing}\mathrm{HIV}‒\mathrm{positive}\mathrm{in}\mathrm{ANC}5\mathrm{months}\mathrm{previously}}$

ANC: Antenatal care; ARV: Antiretroviral; AZT: Azidothymidine; cART: combination antiretroviral therapy; HIV: Human immunodeficiency virus; PCR: Polymerase chain reaction.